iBio Inc (IBIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.31+0.77%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IBIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.1 | 0.4 | 0.2 | 0.0 | 1.9 | 2.4 | 1.6 | 2.0 | 0.4 | 0.4 | 0.9 | 1.9 | 0.2 | 1.0 | 1.3 |
| Total Revenues | — | — | — | — | 0.0 | 1.9 | 2.4 | 1.6 | 2.0 | 0.4 | 0.4 | 0.9 | 1.9 | 0.2 | 1.0 | 1.3 |
| Cost of Revenues | — | — | — | — | — | 0.2 | 1.5 | 0.7 | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | 0.9 | 0.9 | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 19.6 | 19.6 | 8.3 | 5.2 | 10.3 | 9.8 | 10.0 | 3.6 | 5.5 | 4.0 | 4.1 | 3.2 | 3.5 | 1.9 | 3.4 | 5.0 |
| Operating Income | (35.1) | (35.1) | (18.6) | (16.6) | (29.3) | (29.7) | (31.1) | (14.0) | (15.8) | (14.2) | (14.3) | (9.9) | (6.7) | (3.8) | (6.7) | (9.3) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 0.1 | 0.2 | 0.2 | 0.1 | 1.4 | 2.5 | 2.5 | 1.9 | 1.9 | 1.9 | 0.8 | — | 0.0 | 0.1 | 0.1 |
| Interest & Investment Income | 2.2 | 2.2 | 0.4 | 0.4 | 0.2 | 0.2 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | (0.1) | 1.2 | 2.3 | 2.5 | 1.8 | 1.9 | 1.9 | 0.8 | — | (0.0) | 0.1 | 0.1 |
| Other Non-Operating Income / Expenses | 2.1 | 2.1 | 0.2 | 1.2 | 0.0 | 0.2 | 7.9 | (2.4) | (1.8) | (1.9) | (1.9) | (0.8) | 0.0 | 0.2 | 0.5 | 0.0 |
| EBT, Incl. Unusual Items | — | (33.0) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Earnings from Continuing Operations | — | — | (18.4) | (15.4) | (29.3) | (29.5) | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (1.6) | (0.9) | — | — | — | — |
| Net Income | (32.8) | (33.0) | (18.4) | (24.9) | (65.0) | (50.3) | (23.2) | (16.4) | (17.6) | (16.1) | (14.5) | (9.8) | (6.6) | (3.7) | (6.2) | (5.7) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (0.32) | (1.75) | (6.50) | (106.19) | (5.78) | (3.00) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | — | (0.32) | (1.75) | (6.50) | (106.19) | (5.78) | (3.00) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | — | 104.1 | 10.5 | 3.8 | 0.6 | 8.7 | 7.8 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | — | 104.1 | 10.5 | 3.8 | 0.6 | 8.7 | 7.8 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | — | — | — | — | — | (13.8) | (15.6) | — | — | — | — | — | — | (9.0) |
| EBIT | (35.1) | (35.1) | (18.6) | (16.6) | (29.3) | (29.7) | (31.1) | (14.0) | (15.8) | (14.2) | (14.3) | (9.9) | (6.7) | (3.8) | (6.7) | (9.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.